Thursday, December 5, 2024
HomeTagsBrenig Therapeutics

Brenig Therapeutics

Brenig Therapeutics Launches First Human Trial of BT-267 for Parkinson’s

Brenig Therapeutics announced the initiation of the first-in-human clinical trial for BT-267, a best-in-class LRRK2 inhibitor developed as a potential disease-modifying treatment for idiopathic...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics